Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Medullary × fluorodopa F 18 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroendocrine Tumors 1 Carcinoma, Medullary 1

Interventions

lenvatinib 1 fluorodopa F 18 1 cabozantinib 1 Surgical Procedures, Operative 1 Standard of Care 1 Restraint, Physical 1 Radiofrequency Ablation 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Laser Therapy 1 Gefitinib 1 Ferrosoferric Oxide 1 Decision Support Techniques 1 Cryosurgery 1 Cryoelectron Microscopy 1 Absorptiometry, Photon 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02856347 2025-11-18

CMTpostopFDOPA

Institut Claudius Regaud

Phase NA Completed

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡